Literature DB >> 16810113

CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.

Charles B Holmes1, Robin Wood, Motasim Badri, Sophia Zilber, Bingxia Wang, Gary Maartens, Hui Zheng, Zhigang Lu, Kenneth A Freedberg, Elena Losina.   

Abstract

OBJECTIVES: To determine the rate of CD4 decline and the incidence of opportunistic infections (OIs) among antiretroviral therapy-naive South African HIV-infected patients and inform timing of OI prophylaxis.
METHODS: We used mixed-effect models to estimate CD4 cell decline by CD4 cell count strata in HIV-infected patients in the Cape Town AIDS Cohort between 1984 and 2000. Stratum-specific OI incidence per 100 person-years of observation was determined using incidence density analysis.
RESULTS: Nine hundred seventy-four patients with 2 or more CD4 cell counts were included. CD4 counts declined by 47.1 cells/microL per year in the stratum with more than 500 cells/microL stratum, 30.6 cells/microL per year in the stratum with 351 to 500 cells/microL, and 20.5 cells/microL per year in the stratum with 201 to 350 cells/microL. Tuberculosis and oral candidiasis were the only OIs that occurred frequently in the stratum with more than 200 CD4 cells/microL. Rates of chronic diarrhea, wasting syndrome, tuberculosis, and oral and esophageal candidiasis increased in the stratum with less than 200 cells/microL, and rates of all OIs were highest in the stratum with 50 cells/microL or less.
CONCLUSIONS: : CD4 cell count declines were dependent on CD4 strata and can inform timing of clinic visits and treatment initiation in South Africa. Incidence rates of OIs suggest that targeted OI prophylaxis could prevent substantial HIV-related morbidity in South Africa.

Entities:  

Mesh:

Year:  2006        PMID: 16810113     DOI: 10.1097/01.qai.0000225729.79610.b7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  98 in total

1.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

2.  HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005.

Authors:  Elena Losina; Peter Figueroa; Jacqueline Duncan; Nomita Divi; Lindsey L Wolf; Lisa R Hirschhorn; Minnette Robertson; Kevin Harvey; Sheldon Whorms; Kenneth A Freedberg; Yitades Gebre
Journal:  Int J Infect Dis       Date:  2007-08-13       Impact factor: 3.623

3.  New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya.

Authors:  John Mansoer; Suzanne Scheele; Katherine Floyd; Christopher Dye; Joseph Sitienei; Brian Williams
Journal:  Bull World Health Organ       Date:  2009-03       Impact factor: 9.408

4.  The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection.

Authors:  David W Dowdy; Richard E Chaisson
Journal:  Bull World Health Organ       Date:  2009-04       Impact factor: 9.408

5.  Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.

Authors:  Rochelle P Walensky; Eric L Ross; Nagalingeswaran Kumarasamy; Robin Wood; Farzad Noubary; A David Paltiel; Yoriko M Nakamura; Sheela V Godbole; Ravindre Panchia; Ian Sanne; Milton C Weinstein; Elena Losina; Kenneth H Mayer; Ying Q Chen; Lei Wang; Marybeth McCauley; Theresa Gamble; George R Seage; Myron S Cohen; Kenneth A Freedberg
Journal:  N Engl J Med       Date:  2013-10-31       Impact factor: 91.245

6.  Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis.

Authors:  Eran Bendavid; Sean D Young; David A Katzenstein; Ahmed M Bayoumi; Gillian D Sanders; Douglas K Owens
Journal:  Arch Intern Med       Date:  2008-09-22

Review 7.  The potential role for probiotic yogurt for people living with HIV/AIDS.

Authors:  Gregor Reid
Journal:  Gut Microbes       Date:  2010 Nov-Dec

8.  HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.

Authors:  Noah Kiwanuka; Merlin Robb; Oliver Laeyendecker; Godfrey Kigozi; Fred Wabwire-Mangen; Fredrick E Makumbi; Fred Nalugoda; Joseph Kagaayi; Michael Eller; Leigh Anne Eller; David Serwadda; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Christopher C Whalen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

9.  Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis.

Authors:  Eran Bendavid; Robin Wood; David A Katzenstein; Ahmed M Bayoumi; Douglas K Owens
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

Review 10.  Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.

Authors:  Stephen D Lawn; Katharina Kranzer; Robin Wood
Journal:  Clin Chest Med       Date:  2009-12       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.